Osuga Takahiro, Tanaka Shingo, Kubo Tomohiro, Hamaguchi Kota, Ito Ryo, Sakurada Akira, Ishikawa Keidai, Miyanishi Koji
Department of Medical Oncology, Sapporo Medical University School of Medicine, Hokkaido, Japan.
Department of Infection Control and Laboratory Medicine, Sapporo Medical University School of Medicine, Hokkaido, Japan.
Case Rep Oncol. 2024 Mar 1;17(1):407-416. doi: 10.1159/000536498. eCollection 2024 Jan-Dec.
Single distant metastases after radiofrequency ablation (RFA) of hepatocellular carcinoma (HCC) are rare. There are no guidelines for treating patients without liver tumors after resecting lung metastases.
Here, we report a patient with HCC recurring as a single lung metastasis 14 months after RFA. A 76-year-old woman with primary biliary cholangitis without hepatitis B virus or hepatitis C virus infection had been treated by RFA for a single 16-mm-sized HCC lesion in liver S8. Fourteen months thereafter, despite lack of intrahepatic recurrence, a single new 26-mm-sized mass was found in S10 of the right lung. The patient underwent right lower lobectomy. The histopathological diagnosis was HCC metastasis. Because no residual disease could be found, she was followed up without any additional treatment after surgery. She remains alive with no signs of recurrence 3 years later.
HCC patients who relapse with lung metastases but without intrahepatic recurrence after RFA are extremely rare, especially when RFA is used to treat HCC lesions <30 mm. However, it should be noted that, although rare, HCC may recur in the form of extrahepatic metastases after RFA. Furthermore, it is suggested that, as in the presently-described case, at least some patients without intrahepatic recurrence whose lung metastases are completely resected have a good prognosis even without additional treatment for HCC.
肝细胞癌(HCC)经射频消融(RFA)后出现单一远处转移罕见。对于切除肺转移灶后无肝肿瘤的患者,尚无治疗指南。
在此,我们报告1例患者,RFA治疗14个月后HCC复发为单一肺转移。1例76岁女性,原发性胆汁性胆管炎,无乙肝病毒或丙肝病毒感染,因肝脏S8区一个16mm大小的HCC病灶接受RFA治疗。14个月后,尽管无肝内复发,但在右肺S10区发现一个新的26mm大小的肿块。患者接受右下叶切除术。组织病理学诊断为HCC转移。因未发现残留病灶,术后未进行任何额外治疗,对其进行随访。3年后她仍存活,无复发迹象。
RFA治疗后出现肺转移但无肝内复发的HCC患者极为罕见,尤其是RFA用于治疗<30mm的HCC病灶时。然而,应注意的是,尽管罕见,但RFA后HCC可能以肝外转移的形式复发。此外,如本病例所示,至少部分无肝内复发且肺转移灶完全切除的患者,即使未接受HCC的额外治疗,预后也良好。